Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D 1 , D 2 and D 3 receptors

By Perachon S.   Schwartz J.-C.   Sokoloff P.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 293-300

Elsevier

Access to resources Recommend Favorite

Gene Electrotransfer in 3D Reconstructed Human Dermal Tissue

By  

Current Gene Therapy, Vol. 16, Iss. 2, 2016-04 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

2D, 3D and 4D Active Compound Delivery in Tissue Engineering and Regenerative Medicine

By  

Current Pharmaceutical Design, Vol. 21, Iss. 12, 2015-04 ,pp. : 1506-1516

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 2, 2006-01 ,pp. : 175-187

Bentham Science Publishers

Access to resources Recommend Favorite

Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors

By  

Current Computer - Aided Drug Design, Vol. 11, Iss. 3, 2015-09 ,pp. : 245-257

Bentham Science Publishers

Access to resources Recommend Favorite